Factors influencing behavioral intention regarding prostate cancer screening among older African-American men

Journal of the National Medical Association

Volumn 98, Issue 4, 2006, Pages 505-514

  Ford, Marvella E ^a   Vernon, Sally W ^b   Havstad, Suzanne L ^b   Thomas, Shirley A ^b   Davis, Shawna D ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

African Americans; Health screening; Men's health; Preventive medicine; Prostate cancer

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER SCREENING; CLINICAL ARTICLE; CODING; CONCEPTUAL FRAMEWORK; DECISION MAKING; DIAGNOSTIC TEST; HEALTH INSURANCE; HUMAN; MALE; MEDICAL INFORMATION; MOTIVATION; NON PROFIT HOSPITAL; PRIORITY JOURNAL; PROSTATE CANCER; RISK FACTOR;

AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; FOCUS GROUPS; HEALTH BEHAVIOR; HUMANS; INTENTION; MALE; MASS SCREENING; MIDDLE AGED; PREVENTIVE HEALTH SERVICES; PROSTATIC NEOPLASMS;

EID: 33645696250     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Platz EA, Pollak MN, Rimm EB, et al. Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men. Cancer Epidemiol Biomarkers Prev. 1999;8(12):1107-1110.
2. Blumenthal DS, Sung J, Coates R, et al. Recruitment and retention of subjects for a longitudinal cancer prevention study in an inner-city black community. Health Serv Res. 1995;30(1 Pt 2):197-205.
3. Powell IJ, Banerjee M, Novallo M, et al. Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease. Urology. 2000;55(2):246-251.
4. Myers RE, Chodak GW, Wolf TA, et al. Adherence by African American men to prostate cancer education and early detection. Cancer. 1999;86 (1):88-104.
5. Smith GE, DeHaven MJ, Grundig JP, et al. African-American males and prostate cancer, assessing knowledge levels in the community. J Natl Med Assoc. 1997;89(6):387-391.
6. Powell IJ, Heilbrun LK, Sakr W, et al. The predictive value of race as a clinical prognostic factor among patients with clinically localized prostate cancer, a multivariate analysis of positive surgical margins. Urology. 1997;49(5):726-731.
7. DeAntoni EP, Crawford ED, Oesterling JE, et al. Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study. Urology. 1996;48(2):234-239.
8. Powell IJ, Schwartz K, Hussain M. Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system. Urology. 1995;46(6):825-830.
9. Ndubuisi SC, Kofie VY, Andoh JY, et al. Black-white differences in the stage at presentation of prostate cancer in the District of Columbia. Urology. 1995;46(1):71-77.
10. Mouton CP. Special health considerations in African-American elders. Am Fam Physician. 1997;55(4):1243-1253.
11. Fowler FJ Jr, Bin L, Collins MM, et al. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists. Am J Med. 1998;104(6):526-532.
12. Lu-Yao G, Stukel TA, Yao SL. Prostate-specific antigen screening in elderly men. J Natl Cancer Inst. 2003;95(23):1792-1797.
13. McNaughton-Collins M, Fowler FJ Jr, Caubet JF, et al. Psychological effects of a suspicious prostate cancer screening test followed by a benign biopsy result. Am J Med. 2004;117(10):719-725.
14. Ransohoff DF, McNaughton CM, Fowler FJ. Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback. Am J Med. 2002;113(8):663-667.
15. Gattellari M, Ward JE. A community-based randomised controlled trial of three different educational resources for men about prostate cancer screening. Patient Educ Couns. 2005;57(2):168-182.
16. Stevenson FA, Barry CA, Britten N, et al. Doctor-patient communication about drugs: the evidence for shared decision making. Soc Sci Med. 2000;50(6):829-840.
17. Piercy GB, Deber R, Trachtenberg J, et al. Impact of a shared decision-making program on patients with benign prostatic hyperplasia. Urology. 1999;53(5):913-920.
18. Gafni A, Charles C, Whelan T. The physician-patient encounter: the physician as a perfect agent for the patient versus the informed treatment decision-making model. Soc Sci Med. 1998;47(3):347-354.
19. Kohler CL, Dolce JJ, Manzella BA, et al. Use of focus group methodology to develop an asthma self-management program useful for community-based medical practices. Health Educ Q. 1993;20(3):421-429.
20. Bailey EJ, Erwin DO, Belin P. Using cultural beliefs and patterns to improve mammography utilization among African-American women: the Witness Project. J Natl Med Assoc. 2000;92(3):136-142.
21. Vuckovic N, Ritenbaugh C, Taren DL, et al. A qualitative study of participants' experiences with dietary assessment. J Am Diet Assoc. 2000;100(9):1023-1028.
22. Nyamathi A, Shuler P. Focus group interview: a research technique for informed nursing practice. J Adv Nurs. 1990;15(11):1281-1288.
23. Bulmer C. Clinical decisions: defining meaning through focus groups. Nursing Standard. 1998;12(20):34-36.
24. Beaudin CL, Pelletier LR. Consumer-based research: using focus groups as a method for evaluating quality of care. J Nurs Care Qual. 1996;10(3):28-33.
25. Esposito N, Powell-Cope G, Haley JA. Avoiding pitfalls in focus group research. Sci Nursing. 1997;14(1):31-33.
26. Sim J. Collecting and analysing qualitative data: issues raised by the focus group. J Adv Nurs. 1998;28(2):345-352.
27. Myers RE, Hyslop T, Wolf TA, et al. African-American men and intention to adhere to recommended follow-up for an abnormal prostate cancer early detection examination result. Urology. 2000;55(5):716-720.
28. Becker MH, Maiman LA, Kirscht JP, et al. The Health Belief Model and prediction of dietary compliance: a field experiment. J Health Soc Behav. 1977;18(4):348-366.
29. Becker MH, Radius SM, Rosenstock IM, et al. Compliance with a medical regimen for asthma: a test of the health belief model. Public Health Rep. 1978;93(3):268-277.
30. Janz NK, Becker MH. The Health Belief Model: a decade later. Health Educ Q. 1984;11(1):1-47.
31. Fisher EB Jr, Sussman LK, Arfken C, et al. Targeting high risk groups. Neighborhood organization for pediatric asthma management in the Neighborhood Asthma Coalition. Chest. 1994;106(4 Suppl):248S-259S.
32. Gulick EE. Social support among persons with multiple sclerosis. Res Nurs Health. 1994;17(3):195-206.
33. Williams HA. A comparison of social support and social networks of black parents and white parents with chronically ill children. Soc Sci Med. 1993;37(12):1509-1520.
34. Kang SH, Bloom JR, Romano PS. Cancer screening among African-American women: their use of tests and social support. Am J Public Health. 1994;84(1):101-103.
35. Clarke-Tasker VA, Wade R. What we thought we knew: African American males' perceptions of prostate cancer and screening methods. ABNF J. 2002;13(3):56-60.
36. Nivens AS, Herman J, Weinrich S, et al. Cues to participation in prostate cancer screening: a theory for practice. Oncol Nurs Forum. 2001;28(9):1449- 1456.
37. Krueger RA. Analyzing and Responding to Focus Group Results. In: Morgan DL, Krueger RA, eds. The Focus Group Kit. Sage Publications Inc.; 1998.
38. Morgan DL. Focus Groups as Qualitative Research. [16]. In: Morgan DL, eds. Qualitative Research Methods Series. Newbury Park, CA: Sage Publications Inc.; 1988.
39. Thom DH, Campbell B. Patient-physician trust: an exploratory study. J Fam Pract. 1997;44(2):169-176.
40. Shelton P, Weinrich S, Reynolds WA Jr. Barriers to prostate cancer screening in African American men. J Natl Black Nurses Assoc. 1999;10(2):14-28.
41. Forrester-Anderson IT. Prostate Cancer Screening Perceptions, Knowledge and Behaviors among African American Men: Focus Group Findings, J Health Care Poor Underserved. 2005;16(4):22-30.
42. Weinrich SP, Reynolds WA Jr, Tingen MS, et al. Barriers to prostate cancer screening. Cancer Nurs. 2000;23(2):117-121.
43. Weinrich SP, Weinrich M, Reynolds WA Jr, et al. Urinary symptoms as a predictor for participation in prostate cancer screening among African American men. Prostate. 1998;37(4):214-222.
44. Weinrich SP, Greiner E, Reos-Starr C, et al. Predictors of participation in prostate cancer screening at worksites. J Community Health Nurs. 1998;15 (2):113-129.
45. Woods VD, Montgomery SB, Belliard JC, et al. Culture, black men, and prostate cancer: what is reality? Cancer Control. 2004;11(6):388-396.
46. Hall JD, Boyd JC, Lippert MC, et al. Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey. Urology. 2003;61(2):402-407.
47. Ford S, Schofield T, Hope T. What are the ingredients for a successful evidence-based patient choice consultation?: a qualitative study. Soc Sci Med. 2003;56(3):589-602.
48. Barry MJ, Fowler FJ Jr, Mulley AG, et al. Patient reactions to a program designed to facilitate patient participation in treatment decisions for benign prostatic hyperplasia. Med Care. 1995;33(8):771-782.
49. Cohen H, Britten N. Who decides about prostate cancer treatment? A qualitative study. Fam Pract. 2003;20(6):724-729.
50. Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med. 1997;44(5):681-692.
51. Ahaghotu C, Baffoe-Bonnie A, Kittles R, et al. Clinical characteristics of African-American men with hereditary prostate cancer: the AAHPC Study. Prostate Cancer Prostatic Dis. 2004;7(2):165-169.
52. Bock CH, Peyser PA, Gruber SB, et al. Prostate cancer early detection practices among men with a family history of disease. Urology. 2003;62(3):470-475.
53. Bunting PS. Screening for prostate cancer with prostate-specific antigen: beware the biases. Clin Chim Acta. 2002;315(1-2):71-97.
54. Ghafoor A, Jemal A, Cokkinides V, et al. Cancer statistics for African Americans. CA Cancer J Clin. 2002;52(6):326-341.
55. Gray MA, Delahunt B, Fowles JR, et al. Demographic and clinical factors as determinants of serum levels of prostate specific antigen and its derivatives. Anticancer Res. 2004;24(3b):2069-2072.
56. Guo Y, Sigman D, Borkowski A, et al. Racial differences in prostate cancer growth: apoptosis and cell proliferation in Caucasian and African-American patients. Prostate. 2000;42(2):130-136.
57. Stallings FL, Ford ME, Simpson NK, et al. Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2000;21(6 Suppl):379S-389S.